Latest Articles
Meet a graduating nursing student inspired by personal experiences to advocate for patients - Case Western Reserve University
Meet a graduating nursing student inspired by personal experiences to advocate for patients Case Western Reserve University
Published: April 21, 2026, 11:32 a.m.
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News
Published: April 15, 2026, 4:59 p.m.
Dedicated fertility-treatment pathway for women with endometriosis - Nursing Times
Dedicated fertility-treatment pathway for women with endometriosis Nursing Times
Published: March 31, 2026, 2:02 p.m.
Fertility pathway for women with endometriosis added to NICE guideline - Nursing in Practice
Fertility pathway for women with endometriosis added to NICE guideline Nursing in Practice
Published: March 31, 2026, 7:52 a.m.
Interview: closing the nine-year gap in endometriosis diagnosis - Nursing in Practice
Interview: closing the nine-year gap in endometriosis diagnosis Nursing in Practice
Published: March 5, 2026, 12:46 p.m.
Average time for UK endometriosis diagnosis surpasses nine years - Nursing in Practice
Average time for UK endometriosis diagnosis surpasses nine years Nursing in Practice
Published: March 5, 2026, 12:41 p.m.
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News
Published: Feb. 5, 2026, 5:03 p.m.
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? - Oncology Nursing News
Why Does Rina-S Target Folate Receptor Alpha in Endometrial Cancer? Oncology Nursing News
Published: Jan. 14, 2026, 7:32 p.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Treatment for Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer - Cancer Nursing Today
Phase 3 RUBY Trial: Dostarlimab Combination Prolongs Time to Next Therapy for Advanced Endometrial Cancer Cancer Nursing Today
Published: Dec. 15, 2025, 8:24 p.m.
Link copied to clipboard!